Drug delivery, formulation

(elenabs/iStock via Getty Images Plus)

Latest FDA COVID-19 updates

By Jenni Spinner

The federal agency continues to offer advice and take actions related to COVID-19, impacting drug development, clinical trials and other activities.

(Image: Getty/gorodenkoff)

Avalere: FDA can impact COVID-era drug development

By Jenni Spinner

A representative of the life-sciences consulting firm outlines how the federal agency has reacted to the COVID-19 pandemic, and how it might advise the industry going forward.

(Image: Nanoform)

Nanoform granted GMP certification

By Jenni Spinner

The Finnish nanoparticle technology specialist’s facility has been given the stamp of approval by the Finnish Medicines Agency.

(Image: Getty/ffrikretow)

Weekly FDA COVID-19 update

By Jenni Spinner

The agency continues to remain busy overseeing and approving potential treatments and tests for the virus behind the global pandemic.

(Image: Getty/ffikretow)

FDA COVID-19 response roundup

By Jenni Spinner

The federal agency continues to take action and make announcements centered on nationwide efforts to combat the virus causing the global pandemic.

(Image: Getty/Rafael Abdrakhmanov)

FDA updates and actions on COVID-19

By Jenni Spinner

The federal agency has announced a slew of legislation, advisory statements and other items impacting the US in the face of the pandemic.